New VOYAGER PAD Analysis Confirms Consistent Benefit of XARELTO® (rivaroxaban) Plus Aspirin Following Lower Extremity Revascularization (LER) ...Middle East

Findings presented at ACC.23 show XARELTO® plus aspirin provides a 33 percent reduction in acute limb ischemia following LER, with consistent benefit demonstrated at 30 days, 90 days and up to three years Patients who undergo LER are four times more likely to experience acute limb...

Read More Details
Finally We wish PressBee provided you with enough information of ( New VOYAGER PAD Analysis Confirms Consistent Benefit of XARELTO® (rivaroxaban) Plus Aspirin Following Lower Extremity Revascularization (LER) )

Also on site :

• Today’s NYT ‘Strands’ Hints, Spangram and Answers for Friday, July 4
• Ministry of Economy Establishes the Syrian-Canadian Business Council
• Beloved ‘60s Icon, 75, Dazzles London Event in Chic Pink Blazer and High-Top Sneakers